Profile
Casey C.
Kopczynski was the founder of Aerie Pharmaceuticals, Inc. founded in 2005, where he held the title of Chief Innovation Officer in 2022.
He previously worked as Director-Research at Exelixis, Inc. from 1996 to 2002, Vice President-Research at Ercole Biotech, Inc. in 2003, and as Managing Partner at Biotech Initiative LLC from 2002 to 2005.
Dr. Kopczynski earned a doctorate degree from Indiana University.
Former positions of Casey C. Kopczynski
| Companies | Position | End |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Founder | 2022-11-20 |
| Biotech Initiative LLC | Corporate Officer/Principal | - |
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The private company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Chief Tech/Sci/R&D Officer | - |
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | 2001-12-31 |
Training of Casey C. Kopczynski
| Indiana University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The private company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
| Biotech Initiative LLC |
- Stock Market
- Insiders
- Casey C. Kopczynski